1997 Minnesota Statutes

     62J.685 Prescription drug price disclosure. 

    By January 1, 1998, and annually thereafter, a health plan 
 company or hospital licensed under chapter 144 must submit to 
 the attorney general the total amount of:  (1) aggregate 
 purchases of prescription drugs, and (2) discount, rebate, or 
 other payment received during the previous calendar year for 
 aggregate purchases of prescription drugs, including any fee 
 associated with education, data collection, research, training 
 or market share movement received from a manufacturer as defined 
 under section 151.44, paragraph (c), or wholesale drug 
 distributor as defined under section 151.44, paragraph (d).  The 
 identification of individual manufacturers or wholesalers or 
 specific drugs is not required.  The attorney general shall make 
 this information available to the public through the information 
 clearinghouse under section 62J.2930. 

    HIST: 1997 c 202 art 2 s 35